LEIDY CARABALLO GALVA

Concepts (20)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Hepatocellular
2
2021
938
0.780
Why?
Liver Neoplasms
2
2021
1315
0.700
Why?
Immunotherapy
1
2020
663
0.470
Why?
Immunotherapy, Adoptive
1
2020
825
0.430
Why?
Glypicans
1
2021
39
0.190
Why?
T-Lymphocytes
2
2020
1696
0.190
Why?
alpha-Fetoproteins
1
2020
132
0.160
Why?
Xenograft Model Antitumor Assays
1
2021
887
0.160
Why?
Cancer Vaccines
1
2020
177
0.150
Why?
Receptors, Antigen, T-Cell
1
2020
479
0.130
Why?
Antibodies, Monoclonal
1
2021
1015
0.130
Why?
Mice
2
2021
17716
0.070
Why?
Animals
2
2021
34094
0.050
Why?
Humans
3
2021
124083
0.040
Why?
HLA-A2 Antigen
1
2020
25
0.040
Why?
Pyrophosphatases
1
2020
19
0.040
Why?
Phosphoric Diester Hydrolases
1
2020
62
0.040
Why?
Cross Reactions
1
2020
193
0.040
Why?
Lymphocyte Activation
1
2020
684
0.040
Why?
Cells, Cultured
1
2020
3054
0.030
Why?
CARABALLO GALVA's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (20)
Explore
_
Similar People (60)
Explore
_